Home Transfusion for HEME

Description

The purpose of the research is to assess the feasibility and acceptability of a home blood transfusion program for patients with hematologic malignancies who need blood transfusions

Conditions

Hematologic Malignancy

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of the research is to assess the feasibility and acceptability of a home blood transfusion program for patients with hematologic malignancies who need blood transfusions

A Home Transfusion Program for Patients With Advanced Hematologic Malignancies

Home Transfusion for HEME

Condition
Hematologic Malignancy
Intervention / Treatment

-

Contacts and Locations

Boston

Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients with advanced hematologic malignancies:
  • * Diagnosis of a hematologic malignancy
  • * Age ≥ 18 years
  • * Receipt of primary oncologic care at DFCI (at least 2 outpatient visits in 12 months prior to enrollment)
  • * Has received at least one red blood cell (RBC) or platelet transfusion since blood cancer diagnosis in the clinic or hospital setting without a serious adverse transfusion reaction
  • * Physician-estimated prognosis of six months or less
  • * Has an adult informal caregiver that lives in the same residence
  • * Patient resides within catchment served by Care Dimensions Hospice
  • * Caregivers:
  • * Identified informal caregiver of enrolled patient with hematologic malignancy
  • * Age ≥ 18 years
  • * Patients
  • * Age \< 18 years
  • * Does not have an identified adult informal caregiver who lives in the same residence
  • * History of previous serious adverse transfusion reaction
  • * Presence of decompensated congestive heart failure
  • * Caregiver
  • * Age \< 18 years
  • * Our study will exclude members of the following special populations:
  • * Adults unable to consent
  • * Individuals who are not yet adults (infants, children, teenagers)
  • * Pregnant women
  • * Prisoners

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Dana-Farber Cancer Institute,

Oreofe O Odejide, MD, MPH, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

2025-08-31